Advertisement
Screener

ACTINIUM PHARMACEUTICALS, INC. (ATNM) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

ACTINIUM PHARMACEUTICALS, INC. Stock-Based Compensation

ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Stock-Based Compensation of $129.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-07

  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $118.00K, a 40.10% decline year-over-year.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $11.00K, a 99.88% decline year-over-year.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $10.00K, a 99.17% decline year-over-year.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $109.00K, a 91.85% decline year-over-year.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $9.19M, a 73.66% increase from fiscal 2024.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $5.29M, a 37.74% increase from fiscal 2023.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.84M, a 37.46% increase from fiscal 2022.
  • ACTINIUM PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.79M, a 64.99% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$118.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$129.00K
10-Q · filed 2026-08-07
$139.00K
derived: sum of 3 quarters · filed 2026-08-07
$248.00K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$11.00K
10-Q · filed 2026-05-08
$21.00K
derived: sum of 2 quarters · filed 2026-05-08
$130.00K
derived: sum of 3 quarters · filed 2026-05-08
$327.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$119.00K
derived: sum of 2 quarters · filed 2026-03-30
$316.00K
derived: sum of 3 quarters · filed 2026-08-07
$9.19M
10-K · filed 2026-03-30
2025-09-30$109.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$306.00K
derived: sum of 2 quarters · filed 2026-08-07
$9.18M
10-Q · filed 2025-11-14
$10.38M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$197.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$9.07M
10-Q · filed 2026-08-07
$10.27M
derived: sum of 3 quarters · filed 2026-08-07
$11.61M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$8.87M
10-Q · filed 2026-05-08
$10.08M
derived: sum of 2 quarters · filed 2026-05-08
$11.41M
derived: sum of 3 quarters · filed 2026-05-08
$12.79M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$2.54M
derived: sum of 2 quarters · filed 2026-03-30
$3.91M
derived: sum of 3 quarters · filed 2026-03-30
$5.29M
10-K · filed 2026-03-30
2024-09-30$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$2.71M
derived: sum of 2 quarters · filed 2025-11-14
$4.09M
10-Q · filed 2025-11-14
$5.02M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$1.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$2.75M
10-Q · filed 2025-08-08
$3.68M
derived: sum of 3 quarters · filed 2025-08-08
$4.60M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$1.38M
10-Q · filed 2025-05-09
$2.31M
derived: sum of 2 quarters · filed 2025-05-09
$3.23M
derived: sum of 3 quarters · filed 2025-05-09
$4.23M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$927.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$1.85M
derived: sum of 2 quarters · filed 2025-03-31
$2.85M
derived: sum of 3 quarters · filed 2025-03-31
$3.84M
10-K · filed 2025-03-31
2023-09-30$921.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.92M
derived: sum of 2 quarters · filed 2024-11-14
$2.92M
10-Q · filed 2024-11-14
$3.89M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$1.99M
10-Q · filed 2024-08-05
$2.97M
derived: sum of 3 quarters · filed 2024-08-05
$3.94M
derived: sum of 4 quarters · filed 2024-08-05
2023-03-31$993.00K
10-Q · filed 2024-04-26
$1.97M
derived: sum of 2 quarters · filed 2024-04-26
$2.94M
derived: sum of 3 quarters · filed 2024-04-26
$3.37M
derived: sum of 4 quarters · filed 2024-04-26
2022-12-31$979.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$1.95M
derived: sum of 2 quarters · filed 2024-03-29
$2.37M
derived: sum of 3 quarters · filed 2024-03-29
$2.79M
10-K · filed 2024-03-29
2022-09-30$970.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$1.40M
derived: sum of 2 quarters · filed 2023-11-02
$1.82M
10-Q · filed 2023-11-02
$2.26M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$425.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$846.00K
10-Q · filed 2023-08-14
$1.29M
derived: sum of 3 quarters · filed 2023-08-14
$1.71M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$421.00K
10-Q · filed 2023-05-15
$869.00K
derived: sum of 2 quarters · filed 2023-05-15
$1.28M
derived: sum of 3 quarters · filed 2023-05-15
$1.74M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$448.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$859.00K
derived: sum of 2 quarters · filed 2023-03-31
$1.32M
derived: sum of 3 quarters · filed 2023-03-31
$1.69M
10-K · filed 2023-03-31
2021-09-30$411.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$870.00K
derived: sum of 2 quarters · filed 2022-11-14
$1.25M
10-Q · filed 2022-11-14
$1.63M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$459.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$835.00K
10-Q · filed 2022-08-12
$1.22M
derived: sum of 3 quarters · filed 2022-08-12
$1.51M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$376.00K
10-Q · filed 2022-05-13
$760.00K
derived: sum of 2 quarters · filed 2022-05-13
$1.05M
derived: sum of 3 quarters · filed 2022-05-13
$1.26M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$384.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
$672.00K
derived: sum of 2 quarters · filed 2022-03-25
$882.00K
derived: sum of 3 quarters · filed 2022-03-25
$1.25M
10-K · filed 2022-03-25
2020-09-30$288.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$498.00K
derived: sum of 2 quarters · filed 2021-11-12
$870.00K
10-Q · filed 2021-11-12
$1.18M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$210.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$582.00K
10-Q · filed 2021-07-30
$893.00K
derived: sum of 3 quarters · filed 2021-07-30
$1.28M
derived: sum of 4 quarters · filed 2021-07-30
2020-03-31$372.00K
10-Q · filed 2021-05-14
$683.00K
derived: sum of 2 quarters · filed 2021-05-14
$1.07M
derived: sum of 3 quarters · filed 2021-05-14
$1.35M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$311.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$702.00K
derived: sum of 2 quarters · filed 2021-03-31
$979.00K
derived: sum of 3 quarters · filed 2021-03-31
$1.29M
10-K · filed 2021-03-31
$1.29M
10-K · filed 2020-05-08
2019-09-30$391.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23
$668.00K
derived: sum of 2 quarters · filed 2020-10-23
$984.00K
10-Q · filed 2020-10-23
$983.61K
10-Q · filed 2019-11-12
$1.37M
derived: sum of 4 quarters · filed 2020-10-23
2019-06-30$277.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$593.00K
10-Q · filed 2020-08-14
$593.07K
10-Q · filed 2019-08-09
$979.95K
derived: sum of 3 quarters · filed 2020-08-14
$1.39M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$316.00K
10-Q · filed 2020-06-29
$316.39K
10-Q · filed 2019-05-10
$702.95K
derived: sum of 2 quarters · filed 2020-06-29
$1.11M
derived: sum of 3 quarters · filed 2020-06-29
$1.53M
derived: sum of 4 quarters · filed 2020-06-29
2018-12-31$386.95K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08
$792.89K
derived: sum of 2 quarters · filed 2020-05-08
$1.22M
derived: sum of 3 quarters · filed 2020-05-08
$1.80M
10-K · filed 2020-05-08
2018-09-30$405.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$831.76K
derived: sum of 2 quarters · filed 2019-11-12
$1.41M
10-Q · filed 2019-11-12
$2.05M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$425.82K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$1.01M
10-Q · filed 2019-08-09
$1.65M
derived: sum of 3 quarters · filed 2019-08-09
$2.33M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$579.94K
10-Q · filed 2019-05-10
$1.22M
derived: sum of 2 quarters · filed 2019-05-10
$1.90M
derived: sum of 3 quarters · filed 2019-05-10
$3.04M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$639.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$1.32M
derived: sum of 2 quarters · filed 2019-03-15
$2.46M
derived: sum of 3 quarters · filed 2019-03-15
$3.49M
10-K · filed 2019-03-15
2017-09-30$681.82K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$1.82M
derived: sum of 2 quarters · filed 2018-11-09
$2.85M
10-Q · filed 2018-11-09
$4.07M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$1.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$2.17M
10-Q · filed 2018-08-09
$3.39M
derived: sum of 3 quarters · filed 2019-03-15
$4.41M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$1.03M
10-Q · filed 2018-05-10
$2.25M
derived: sum of 2 quarters · filed 2019-03-15
$3.27M
derived: sum of 3 quarters · filed 2019-03-15
$4.34M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31$1.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$2.24M
derived: sum of 2 quarters · filed 2019-03-15
$3.31M
derived: sum of 3 quarters · filed 2019-03-15
$4.30M
10-K · filed 2019-03-15
2016-09-30$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$2.09M
derived: sum of 2 quarters · filed 2017-11-03
$3.08M
10-Q · filed 2017-11-03
$3.83M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$1.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$2.06M
10-Q · filed 2017-08-04
$2.82M
derived: sum of 3 quarters · filed 2018-03-16
$3.95M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$984.84K
10-Q · filed 2017-05-15
$1.74M
derived: sum of 2 quarters · filed 2018-03-16
$2.87M
derived: sum of 3 quarters · filed 2018-03-16
$5.14M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$753.82K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$1.89M
derived: sum of 2 quarters · filed 2018-03-16
$4.15M
derived: sum of 3 quarters · filed 2018-03-16
$7.06M
10-K · filed 2018-03-16
2015-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
$3.40M
derived: sum of 2 quarters · filed 2016-10-28
$6.31M
10-Q · filed 2016-10-28
$7.37M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$2.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29
$5.17M
10-Q · filed 2016-07-29
$6.23M
derived: sum of 3 quarters · filed 2017-03-16
$8.31M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$2.91M
10-Q · filed 2016-05-10
$3.97M
derived: sum of 2 quarters · filed 2017-03-16
$6.05M
derived: sum of 3 quarters · filed 2017-03-16
$7.44M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$3.14M
derived: sum of 2 quarters · filed 2017-03-16
$4.53M
derived: sum of 3 quarters · filed 2017-03-16
$6.28M
10-K · filed 2017-03-16
2014-09-30$2.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
$3.47M
derived: sum of 2 quarters · filed 2015-10-30
$5.22M
10-Q · filed 2015-10-30
$5.60M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$1.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$3.14M
10-Q · filed 2015-08-07
$3.51M
derived: sum of 3 quarters · filed 2016-03-11
$3.61M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$1.75M
10-Q · filed 2015-05-08
$2.12M
derived: sum of 2 quarters · filed 2016-03-11
$2.22M
derived: sum of 3 quarters · filed 2016-03-11
2013-12-31$373.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$469.41K
derived: sum of 2 quarters · filed 2016-03-11
$657.81K
10-K · filed 2016-03-11
2013-09-30$95.97K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
$284.37K
10-Q · filed 2014-10-31
2013-06-30$188.40K
10-Q · filed 2014-08-12
2012-12-31$2.22M
10-K · filed 2014-02-28
2011-12-31$2.17M
10-K · filed 2014-02-28
2010-12-31$21.17K
10-K · filed 2014-02-28
2008-12-31$269.62K
10-K · filed 2014-02-28
2007-12-31$255.06K
10-K · filed 2014-02-28
2006-12-31$252.31K
10-K · filed 2014-02-28
2005-12-31$315.39K
10-K · filed 2014-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
BriaCell Therapeutics Corp. (BCTX)$0.037B
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Incannex Healthcare Inc. (IXHL)$0.040B-22.32